Janux Therapeutics, Inc. (JANX) vs Replimune Group, Inc. (REPL)
- Janux Therapeutics, Inc. JANX 16.49 −4.79%
- Replimune Group, Inc. REPL 10.86 −7.57%
Janux Therapeutics, Inc. and Replimune Group, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and Replimune Group, Inc. are of similar size ($1.1B and $1.1B). Replimune Group, Inc. has the higher net margin (0.00% vs −427.5%) and the lower return on invested capital (−1,154.7% vs 0.00%). Across the 14 metrics below, Janux Therapeutics, Inc. leads on 9 and Replimune Group, Inc. on 5.
Valuation
Profitability
| Metric | JANX | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (598.15%) | 0.00% | 0.00% |
| Net margin | (427.47%) | 0.00% | 0.00% |
| Free cash flow margin | (174.69%) | 0.00% | 0.00% |
| Return on equity | (10.70%) | (134.29%) | (56.36%) |
| Return on assets | (10.06%) | (82.28%) | (48.04%) |
| Return on invested capital | 0.00% | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack